Prostate Cancer Therapeutic Market Report

Japan Prostate Cancer Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 16, 2019
  • PAGES：150
  • REPORT CODE：GMM251690
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Prostate Cancer Therapeutic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Prostate Cancer Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by Prostate Cancer Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Cell Genesys Inc. (USA)

    • Indevus Pharmaceuticals Inc (USA)

    • Immunomedics, Inc. (USA)

    • Dendreon Corporation (USA)

    • Paladin Labs Inc. (Canada)

    • Paladin Labs Inc (Canada)

    • Genentech Inc (USA)

    • Progenics Pharmaceuticals, Inc (USA)

    • EUSA Pharma, (USA) Inc. (USA)

    • ALZA Corporation (USA)

    • Spectrum Pharmaceuticals, Inc. (USA)

    • Indevus Pharmaceuticals Inc. (USA)

    • Amgen Inc. (USA)

    • Pfizer Inc. (USA)

    • OSI Pharmaceuticals, Inc. (USA)

    • Immunomedics, Inc (USA)

    • Cell Genesys Inc (USA)

    • Genentech Inc. (USA)

    • OSI Pharmaceuticals, Inc (USA)

    • F. Hoffmann-La Roche Ltd. (Switzerland)

    • Progenics Pharmaceuticals, Inc. (USA)

    • Bristol-Myers Squibb Company (USA)


    By Type:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Therapeutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.2 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.3 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Prostate Cancer Therapeutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate Cancer Therapeutic by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Prostate Cancer Therapeutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate Cancer Therapeutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prostate Cancer Therapeutic in Application 1

      • 4.4.2 Market Size and Growth Rate of Prostate Cancer Therapeutic in Application 2

      • 4.4.3 Market Size and Growth Rate of Prostate Cancer Therapeutic in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Prostate Cancer Therapeutic Production Analysis by Regions

    • 5.2 Japan Prostate Cancer Therapeutic Consumption Analysis by Regions


    6 Hokkaido Prostate Cancer Therapeutic Landscape Analysis

    • 6.1 Hokkaido Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 6.2 Hokkaido Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    7 Tohoku Prostate Cancer Therapeutic Landscape Analysis

    • 7.1 Tohoku Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 7.2 Tohoku Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    8 Kanto Prostate Cancer Therapeutic Landscape Analysis

    • 8.1 Kanto Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 8.2 Kanto Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    9 Chubu Prostate Cancer Therapeutic Landscape Analysis

    • 9.1 Chubu Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 9.2 Chubu Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    10 Kinki Prostate Cancer Therapeutic Landscape Analysis

    • 10.1 Kinki Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 10.2 Kinki Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    11 Chugoku Prostate Cancer Therapeutic Landscape Analysis

    • 11.1 Chugoku Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 11.2 Chugoku Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    12 Shikoku Prostate Cancer Therapeutic Landscape Analysis

    • 12.1 Shikoku Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 12.2 Shikoku Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    13 Kyushu Prostate Cancer Therapeutic Landscape Analysis

    • 13.1 Kyushu Prostate Cancer Therapeutic Landscape Analysis by Major Types

    • 13.2 Kyushu Prostate Cancer Therapeutic Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Cell Genesys Inc. (USA)

      • 14.1.1 Cell Genesys Inc. (USA) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Indevus Pharmaceuticals Inc (USA)

      • 14.2.1 Indevus Pharmaceuticals Inc (USA) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Immunomedics, Inc. (USA)

      • 14.3.1 Immunomedics, Inc. (USA) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Dendreon Corporation (USA)

      • 14.4.1 Dendreon Corporation (USA) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Paladin Labs Inc. (Canada)

      • 14.5.1 Paladin Labs Inc. (Canada) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Paladin Labs Inc (Canada)

      • 14.6.1 Paladin Labs Inc (Canada) Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Genentech Inc (USA)

      • 14.7.1 Genentech Inc (USA) Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Progenics Pharmaceuticals, Inc (USA)

      • 14.8.1 Progenics Pharmaceuticals, Inc (USA) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 EUSA Pharma, (USA) Inc. (USA)

      • 14.9.1 EUSA Pharma, (USA) Inc. (USA) Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 ALZA Corporation (USA)

      • 14.10.1 ALZA Corporation (USA) Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Spectrum Pharmaceuticals, Inc. (USA)

      • 14.11.1 Spectrum Pharmaceuticals, Inc. (USA) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Indevus Pharmaceuticals Inc. (USA)

      • 14.12.1 Indevus Pharmaceuticals Inc. (USA) Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Amgen Inc. (USA)

      • 14.13.1 Amgen Inc. (USA) Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Pfizer Inc. (USA)

      • 14.14.1 Pfizer Inc. (USA) Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 OSI Pharmaceuticals, Inc. (USA)

      • 14.15.1 OSI Pharmaceuticals, Inc. (USA) Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Immunomedics, Inc (USA)

      • 14.16.1 Immunomedics, Inc (USA) Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Cell Genesys Inc (USA)

      • 14.17.1 Cell Genesys Inc (USA) Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Genentech Inc. (USA)

      • 14.18.1 Genentech Inc. (USA) Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 OSI Pharmaceuticals, Inc (USA)

      • 14.19.1 OSI Pharmaceuticals, Inc (USA) Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 F. Hoffmann-La Roche Ltd. (Switzerland)

      • 14.20.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

    • 14.21 Progenics Pharmaceuticals, Inc. (USA)

      • 14.21.1 Progenics Pharmaceuticals, Inc. (USA) Company Profile and Recent Development

      • 14.21.2 Market Performance

      • 14.21.3 Product and Service Introduction

    • 14.22 Bristol-Myers Squibb Company (USA)

      • 14.22.1 Bristol-Myers Squibb Company (USA) Company Profile and Recent Development

      • 14.22.2 Market Performance

      • 14.22.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 102 Figures and 136 Tables)

     

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prostate Cancer Therapeutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prostate Cancer Therapeutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate Cancer Therapeutic by Different Types from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Therapeutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prostate Cancer Therapeutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Therapeutic by Different End-Users from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Prostate Cancer Therapeutic Production by Regions

    • Table Japan Prostate Cancer Therapeutic Production Share by Regions

    • Figure Japan Prostate Cancer Therapeutic Production Share by Regions in 2014

    • Figure Japan Prostate Cancer Therapeutic Production Share by Regions in 2018

    • Figure Japan Prostate Cancer Therapeutic Production Share by Regions in 2026

    • Table Japan Prostate Cancer Therapeutic Consumption by Regions

    • Table Japan Prostate Cancer Therapeutic Consumption Share by Regions

    • Figure Japan Prostate Cancer Therapeutic Consumption Share by Regions in 2014

    • Figure Japan Prostate Cancer Therapeutic Consumption Share by Regions in 2018

    • Figure Japan Prostate Cancer Therapeutic Consumption Share by Regions in 2026

    • Table Hokkaido Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Hokkaido Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Hokkaido Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Hokkaido Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Tohoku Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Tohoku Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Tohoku Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Tohoku Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Tohoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Kanto Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Kanto Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Kanto Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kanto Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Kanto Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Chubu Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Chubu Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Chubu Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Chubu Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Chubu Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Kinki Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Kinki Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Kinki Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kinki Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Kinki Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Chugoku Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Chugoku Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Chugoku Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Chugoku Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Chugoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Shikoku Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Shikoku Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Shikoku Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Shikoku Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Shikoku Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Kyushu Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

    • Table Kyushu Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by Types in 2014

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by Types in 2018

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by Types in 2026

    • Table Kyushu Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Kyushu Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

    • Figure Kyushu Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Cell Genesys Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Cell Genesys Inc. (USA)

    • Figure Revenue and Market Share Analysis of Cell Genesys Inc. (USA)

    • Table Product and Service Introduction of Cell Genesys Inc. (USA)

    • Table Company Profile and Development Status of Indevus Pharmaceuticals Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc (USA)

    • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc (USA)

    • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc (USA)

    • Table Product and Service Introduction of Indevus Pharmaceuticals Inc (USA)

    • Table Company Profile and Development Status of Immunomedics, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc. (USA)

    • Table Product and Service Introduction of Immunomedics, Inc. (USA)

    • Table Company Profile and Development Status of Dendreon Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation (USA)

    • Figure Sales and Growth Rate Analysis of Dendreon Corporation (USA)

    • Figure Revenue and Market Share Analysis of Dendreon Corporation (USA)

    • Table Product and Service Introduction of Dendreon Corporation (USA)

    • Table Company Profile and Development Status of Paladin Labs Inc. (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc. (Canada)

    • Figure Sales and Growth Rate Analysis of Paladin Labs Inc. (Canada)

    • Figure Revenue and Market Share Analysis of Paladin Labs Inc. (Canada)

    • Table Product and Service Introduction of Paladin Labs Inc. (Canada)

    • Table Company Profile and Development Status of Paladin Labs Inc (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc (Canada)

    • Figure Sales and Growth Rate Analysis of Paladin Labs Inc (Canada)

    • Figure Revenue and Market Share Analysis of Paladin Labs Inc (Canada)

    • Table Product and Service Introduction of Paladin Labs Inc (Canada)

    • Table Company Profile and Development Status of Genentech Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc (USA)

    • Figure Sales and Growth Rate Analysis of Genentech Inc (USA)

    • Figure Revenue and Market Share Analysis of Genentech Inc (USA)

    • Table Product and Service Introduction of Genentech Inc (USA)

    • Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc (USA)

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc (USA)

    • Table Product and Service Introduction of Progenics Pharmaceuticals, Inc (USA)

    • Table Company Profile and Development Status of EUSA Pharma, (USA) Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, (USA) Inc. (USA)

    • Figure Sales and Growth Rate Analysis of EUSA Pharma, (USA) Inc. (USA)

    • Figure Revenue and Market Share Analysis of EUSA Pharma, (USA) Inc. (USA)

    • Table Product and Service Introduction of EUSA Pharma, (USA) Inc. (USA)

    • Table Company Profile and Development Status of ALZA Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation (USA)

    • Figure Sales and Growth Rate Analysis of ALZA Corporation (USA)

    • Figure Revenue and Market Share Analysis of ALZA Corporation (USA)

    • Table Product and Service Introduction of ALZA Corporation (USA)

    • Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc. (USA)

    • Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc. (USA)

    • Table Company Profile and Development Status of Indevus Pharmaceuticals Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc. (USA)

    • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc. (USA)

    • Table Product and Service Introduction of Indevus Pharmaceuticals Inc. (USA)

    • Table Company Profile and Development Status of Amgen Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Amgen Inc. (USA)

    • Figure Revenue and Market Share Analysis of Amgen Inc. (USA)

    • Table Product and Service Introduction of Amgen Inc. (USA)

    • Table Company Profile and Development Status of Pfizer Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Pfizer Inc. (USA)

    • Figure Revenue and Market Share Analysis of Pfizer Inc. (USA)

    • Table Product and Service Introduction of Pfizer Inc. (USA)

    • Table Company Profile and Development Status of OSI Pharmaceuticals, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc. (USA)

    • Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc. (USA)

    • Table Product and Service Introduction of OSI Pharmaceuticals, Inc. (USA)

    • Table Company Profile and Development Status of Immunomedics, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc (USA)

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc (USA)

    • Table Product and Service Introduction of Immunomedics, Inc (USA)

    • Table Company Profile and Development Status of Cell Genesys Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc (USA)

    • Figure Sales and Growth Rate Analysis of Cell Genesys Inc (USA)

    • Figure Revenue and Market Share Analysis of Cell Genesys Inc (USA)

    • Table Product and Service Introduction of Cell Genesys Inc (USA)

    • Table Company Profile and Development Status of Genentech Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Genentech Inc. (USA)

    • Figure Revenue and Market Share Analysis of Genentech Inc. (USA)

    • Table Product and Service Introduction of Genentech Inc. (USA)

    • Table Company Profile and Development Status of OSI Pharmaceuticals, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc (USA)

    • Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc (USA)

    • Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc (USA)

    • Table Product and Service Introduction of OSI Pharmaceuticals, Inc (USA)

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd. (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd. (Switzerland)

    • Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc. (USA)

    • Table Product and Service Introduction of Progenics Pharmaceuticals, Inc. (USA)

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb Company (USA)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US